UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
DECEMBER 16, 1998
-----------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------- ------- ----------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
-------------------------------------------------------
(Address of principal executive offices)
336-229-1127
------------
(Registrant's telephone number, including area code)
<PAGE>
<PAGE>
ITEM 5. OTHER EVENTS
On December 16, 1998, the Company issued a press release
announcing that its Board of Directors has declared
dividends on the Company's 8 1/2% Series A Convertible
Exchangeable Preferred Stock and the Company's 8 1/2%
Series B Convertible Pay-in-Kind Preferred Stock.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS
(c) Exhibit
20 Press release of the Company dated
December 16, 1998.
<PAGE>
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned
hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
------------------------
Bradford T. Smith
Executive Vice President,
General Counsel, Secretary
and Compliance Officer
Date: December 30, 1998
<PAGE>
<PAGE>
Laboratory Corporation of America-Registered Trademark-Holdings
358 South Main Street
Burlington, NC 27215
FOR IMMEDIATE RELEASE
Contact: Pamela Sherry
336-584-5171, Ext. 4855
Shareholder Direct: 800-LAB-0401
www.labcorp.com
LABORATORY CORPORATION OF AMERICA-REGISTERED TRADEMARK- DECLARES
PREFERRED STOCK DIVIDENDS
BURLINGTON, NC, DECEMBER 16, 1998 - Laboratory Corporation of America
Registered Trademark- Holdings (LabCorp-Registered Trademark-) (NYSE:
LH) today announced that its Board of Directors has declared a
dividend of $1.0625 per share on the Company's 8 1/2% Series A
Convertible Exchangeable Preferred Stock (Series A Preferred Stock),
payable in cash. The Board has also declared a dividend of $1.0625
per share on the Company's 8 1/2% Series B Convertible Pay-in-Kind
Preferred Stock (Series B Preferred Stock), payable in shares of
Series B Preferred Stock at the rate of 0.02125 shares per share of
Series B Preferred Stock held. No fractional shares of Series B
Preferred Stock will be issued, so that the number of shares to be
paid as a dividend on the Series B Preferred Stock will be rounded to
the nearest whole number of shares. The dividends will be payable on
December 31, 1998 for each issued and outstanding share of Series A
and B Preferred Stock to stockholders of record on December 22, 1998,
and will cover the dividend period from October 1, 1998 to December
31, 1998 at an equivalent annualized rate of $4.25 per share.
Laboratory Corporation of America-Registered Trademark- Holdings
(LabCorp-Registered Trademark-) is a national clinical laboratory
organization with annual revenues of $1.5 billion in 1997. The
Company operates primary testing facilities nationally, offering more
than 1,700 different clinical assays, from routine blood analyses to
more sophisticated technologies. LabCorp performs diagnostic tests
for physicians, managed-care organizations, hospitals, clinics, long
term care facilities, industrial companies and other clinical
laboratories.
###
_______________________________
